In the present study, anti-CX3CL1 mAb successfully inhibited the migration of M1 macrophages, but failed to suppress the migration and/or polarization of M2 macrophages; therefore, it did not exert therapeutic effects against lung fibrosis with CX3CL1 blockade alone. Here, CX3CL1 is linked to pulmonary fibrosis.